BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3196498)

  • 1. [Clinical symptoms and disability of myotonic dystrophy in Japan].
    Matsuoka Y; Saida K; Nishitani H; Takahashi A
    No To Shinkei; 1988 Oct; 40(10):947-52. PubMed ID: 3196498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence of myotonic dystrophy in Iceland].
    Leifsdóttir G; Benedikz JE; Jóhannesson G; Jónsson JJ; Sveinbjörnsdóttir S
    Laeknabladid; 2005 Nov; 91(11):829-34. PubMed ID: 16264243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical manifestations of myotonic dystrophy: epidemiologic survey].
    López de Munain A; Emparanza JI; Blanco A; Cobo A; Poza JJ; Basauri B; Baiget M; Martí Massó JF
    Med Clin (Barc); 1993 Jun; 101(5):161-4. PubMed ID: 8332007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical studies and ultrastructure in myotonic dystrophy].
    Hou H
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Dec; 22(6):344-5, 382. PubMed ID: 2638986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of participation in myotonic dystrophy: reliability of the LIFE-H.
    Gagnon C; Mathieu J; Noreau L
    Neuromuscul Disord; 2006 Apr; 16(4):262-8. PubMed ID: 16545567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Aug; 443():1-321. PubMed ID: 12595920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myotonic dystrophy in childhood.
    Lanzi G; Besana D; Ottolini A; Venco A
    Acta Neurol Belg; 1982; 82(3):150-8. PubMed ID: 7113652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Orofacial evaluation with a punctuation scale in patients with myotonic dystrophy (Steinert's disease)].
    Noronha CF; Alves Duro LA
    Arq Neuropsiquiatr; 1995 Sep; 53(3-A):424-31. PubMed ID: 8540816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and therapy of myotonic dystrophy in our practice of neuromuscular care].
    Merkli H; Pál E; Trauninger A; Kosztolányi P; Gáti I
    Orv Hetil; 2004 Mar; 145(10):523-8. PubMed ID: 15085591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysphagia is present but mild in myotonic dystrophy type 2.
    Tieleman AA; Knuijt S; van Vliet J; de Swart BJ; Ensink R; van Engelen BG
    Neuromuscul Disord; 2009 Mar; 19(3):196-8. PubMed ID: 19167224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognosis for myotonic dystrophy].
    Saito Y; Honda H; Matsuoka Y
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1489-91. PubMed ID: 8752440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Nov; 465():1-354. PubMed ID: 12579199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and clinical characteristics of bipolar I disorder in Butajira, Ethiopia: a community-based study.
    Negash A; Alem A; Kebede D; Deyessa N; Shibre T; Kullgren G
    J Affect Disord; 2005 Aug; 87(2-3):193-201. PubMed ID: 15913783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of Nickel Subsulfide (CAS No. 12035-72-2) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Jul; 453():1-365. PubMed ID: 12594522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of Nickel Oxide (CAS No. 1313-99-1) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Jul; 451():1-381. PubMed ID: 12594524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oculomotor involvement in myotonic dystrophy type 2.
    Ajroud-Driss S; Sufit R; Siddique T; Hain TC
    Muscle Nerve; 2008 Oct; 38(4):1326-9. PubMed ID: 18785188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.